ADPT
Adaptive Biotechnologies Corporation · Healthcare · Biotechnology
At close
$14.17
+$0.09 (+0.63%) Close
Pre-market $13.95 −$0.22 (−1.55%) 12:22 AM ET
Prev close $14.08
Open $14.01
Day high $14.17
Day low $14.01
Volume 35
Avg vol 2,252,932
Mkt cap
$2.24B
P/E ratio
-35.42
FY Revenue
$276.98M
EPS
-0.40
Gross Margin
74.24%
Sector
Healthcare
AI report sections
ADPT
Adaptive Biotechnologies Corporation
Adaptive Biotechnologies combines rapid share-price appreciation and bullish technical signals with ongoing operating losses and negative free cash flow. The stock is trading near the upper end of its 52-week range with improving revenue and earnings trends but also meaningful short interest and competitive pressures in its core MRD market. Overall positioning reflects a constructive intermediate-term trend balanced against execution, cash-flow, and competitive risks.
AI summarized at 10:57 AM ET, 2026-01-13
AI summary scores
INTRADAY: 68 SWING: 72 LONG: 55
Volume vs average
Intraday (cumulative)
−31% (Below avg)
Vol/Avg: 0.69×
RSI
52.07 (Neutral)
Neutral (40–60)
MACD momentum
Intraday
-0.01 (Weak)
MACD: -0.02 Signal: -0.01
Short-Term
+0.17 (Strong)
MACD: -0.17 Signal: -0.34
Long-Term
+0.15 (Strong)
MACD: -0.78 Signal: -0.93
Intraday trend score 41.86

Latest news

ADPT No articles found.
News is temporarily unavailable.
News and sentiment labels describe article tone and are provided for research purposes only. They are not trading recommendations or forecasts.
Trade Ranks, LLC is not a registered investment adviser or broker-dealer. All rankings and AI reports are for informational and educational purposes only and are not personalized advice. Investing involves risk. Policy Portal